corner
Healthy Skepticism
Join us to help reduce harm from misleading health information.
Increase font size   Decrease font size   Print-friendly view   Print
Register Log in

All items in the Healthy Skepticism Library

All the 20545 items in the Healthy Skepticism Library are listed below in order of publication date with the most recent at the top. There are 100 items per page.

Page 198 of 206 pages ‹ First  < 196 197 198 199 200 >  Last ›

HSL8471
Klein T.
Going public: promoting prescription drugs to consumers
Pharmaceutical Executive 1982 Jun;2:46, 50, 52

HSL8472
Meyers HM.
Packaging: will advertising change prescription drug labeling?
Pharmaceutical Executive 1982 Jun;2:44-45

HSL8470
Gunston G.
Pharmaceutical marketing: predicting prescribing response
Pharmaceutical Journal 1982 May 29;228:619-620

HSL3126
The WHO and the pharmaceutical industry
1982 May 01;

HSL3102
Cohn JN.
Science and advertising.
Circulation 1982 May;65:(5):839-40

HSL3123
Strickland-Hodge B, Jepson MH.
Identification and characterization of early and late prescribers in general practice.
J R Soc Med 1982 May;75:(5):341-5

HSL8473
Accept no substitutes
Pharmaceutical Journal 1982 Apr 17;28:440-441

HSL3121
Soffer A.
Free medical publications or scientific medical journals.
Chest 1982 Apr;81:(4):397-8

HSL3124
Tse CS.
Disclosure of product information by manufacturers.
Am J Hosp Pharm 1982 Apr;39:(4):645-6

HSL8526
Meadows RJ.
Prospectus on new drugs
Drug Merchandising 1982 Apr;63:18-19

HSL8528
Gunston G.
Pharmaceutical marketing: kill or cure?
Pharmaceutical Journal 1982 Mar 20;228:350

HSL13326
Zelino R.
The Interaction among the Criteria Physicians Use When Prescribing
Medical Care 1982 Mar;20:(3):277-85
http://www.lww-medicalcare.com/pt/re/medcare/issuelist.htm

HSL16704
Wolfe SM.
Mis-prescribing: causes and remedies.
Internist 1982 Feb;23:(1):8-10
http://www.ncbi.nlm.nih.gov/pubmed/10257494

HSL3114
O'Brien WM.
Alleged direct promotion of prescription drugs to consumers.
N Engl J Med 1982 Jan 21;306:(3):181-2

HSL2075
Kahneman D, Slovic P, Tversky A.
Judgment under uncertainty: heuristics and biases.
New York: Cambridge University Press 1982
http://www.cambridge.org/uk/catalogue/catalogue.asp?isbn=0521284147

HSL2143
Haayer F.
Rational prescribing and sources of information.
Soc Sci Med 1982;16:(23):2017-23

HSL2714
Buc N.
Current regulatory issues in marketing prescription drugs: Comparative claims and advertising to consumers
Food Drug Cosmetic Law Journal 1982;37:402-408

HSL3096
Drugs and the Third World
Lancet 1982;2:1351

HSL3098
Publicity and the public’s ‘right to know’
New Zealand Pharmacy 1982;2:(6):19, 22

HSL3100
Blum A.
The subject of advertising
Medical Journal of Australia 1982;2:61

HSL3101
Bourbonniere C.
Ethical issues in sponsorship of CME
Canadian Medical Association Journal 1982;127:681

HSL3103
Cooperstock R, Hill J.
The effects of tranquillization: benzodiazepine use in Canada
Health and Welfare Canada 1982;

HSL3104
Defesche CL.
Alleged direct promotion of prescription drugs to consumers
New England Journal of Medicine 1982;306:182

HSL3105
Dunn E, William JI, Bryans AM, Davis D, Delmore T, Herron A, Krauser J, Scott DJ.
Continuing medical education in Ontario: a primary care perspective
Canadian Family Physician 1982;28:1327-1333

HSL3106
Gass DA.
Ethical issues in sponsorship of CME
Canadian Medical Association Journal 1982;127:681

HSL3108
Lanier B.
Drug company advertising to the public
JAMA 1982;248:1163

HSL3109
McMillan JH.
Information about medicines
New Zealand Medical Journal 1982;95:674-675

HSL3110
Medawar C.
Marketing and use of pharmaceuticals—bad information means bad medicine
1982;

HSL3111
Melrose D.
Bitter pills: medicines and the Third World poor
1982;
http://publications.oxfam.org.uk/oxfam/display.asp?K=9780855980658&cat=090,280&ob=SORT_DATE/d&m=43&dc=220

HSL3112
Melville A, Johnson C.
Cured to death: the effects of prescription drugs
1982;

HSL3113
Muller M.
The health of nations: a north-south investigation
: Faber and Faber 1982

HSL3116
Rheinstein PH.
A head start, a broader audience, and an emphasis on difference: The new frontiers of prescription drug promotion
Food Drug Cosmetic Law Journal 1982;37:330-335

HSL3118
Silverman M, Lee PR, Lydecker M.
The drugging of the Third World.
Int J Health Serv 1982;12:(4):585-96

HSL3119
Silverman M, Lee PR, Lydecker M.
Prescriptions for death: the drugging of the Third World
Berkeley: University of California Press 1982;

HSL3122
Soffer A.
Hazards in publication of proceedings
Archives of Internal Medicine 1982;142:2074-2076

HSL3125
Victora CG.
Statistical malpractice in drug promotion: a case-study from Brazil.
Soc Sci Med 1982;16:(6):707-9

HSL5382
US Congress, Office of Technology Assessment
Postmarketing Surveillance of Prescription Drugs
Washington, DC: US Government Publishing Office 1982

HSL8454
Williams P.
Cost of tranquilizers
Social Science and Medicine 1982;16:(22):1955-1958

HSL9075
Medawar C, Freese B.
Drug Diplomacy
London: Social Audit 1982
http://www.socialaudit.org.uk/122order.htm#1.22%20How%20to%20order

HSL12508
Jones S.
Social marketing: dimensions of power and politics.
Eur J Mark 1982;16:(6):46-53
http://www.ncbi.nlm.nih.gov/pubmed/12280422

HSL13275
Hadsall RS, Freeman RA, Norwood GJ.
Factors related to the prescribing of selected psychotropic drugs by primary care physicians.
Soc Sci Med 1982;16:(20):1747-56
http://www.ncbi.nlm.nih.gov/pubmed/7178921

HSL16705
Wolfe SM.
The marketing of a drug.
Health Med 1982 Spr;1:(2):31-2
http://www.ncbi.nlm.nih.gov/pubmed/10257087

HSL8465
Baum C, Rheinstein P.
It is time to change the brief summary?
Pharmaceutical Executive 1981 Nov;1:34, 36, 38-39

HSL3094
Richter R.
Pesticides and pills: for export only Part two: pharmaceuticals
1981 Oct 24;

HSL3095
Freese B, Medawar C, Herxheimer A.
No more lomotil for infants.
Lancet 1981 Oct 10;2:(8250):816-7

HSL8532
Kushner D.
Growing substitution in chains: how will innovating firms respond?
American Druggist 1981 Oct;184:3, 52, 54, 58, 60, 62, 66, 68,

HSL3093
Pazderka B, Rao RC.
Market share competition in the Canadian prescription drug industry: a comparison of several therapeutical markets
1981 Sep;

HSL8464
Thomas WH.
Substitution and generic products
New Zealand Pharmacy 1981 Sep;1:35-37, 43

HSL3079
Koumjian K.
The use of valium as a form of social control.
Soc Sci Med [E] 1981 Aug;15:(3):245-9

HSL8474
Rheinstein PH.
Advertising prescription drugs-first promotional campaign
Drug Information Journal 1981 Jul-Dec;15:125-127

HSL8529
Vertes L.
Interactions of oral antidiabetics
Gyogyszereszet 1981 Jul;25:242-243

HSL3083
Oppenheim GL, Erickson SH, Ashworth C.
The family physician's knowledge of the cost of prescribed drugs.
J Fam Pract 1981 Jun;12:(6):1027-30

HSL8531
Chiles VK.
Self-medication triangle: manufacturer, pharmacist and consumer
Canadian Pharmaceutical Journal 1981 Jun;114:220-221, 228

HSL8538
Feldmann EG.
Preclearance of drug products--pharmacy's perspective.
Am Pharm 1981 Jun;NS21:(6):26-32

HSL3092
Culliton BJ.
Biomedical research enters the marketplace
New England Journal of Medicine 1981 May 14;304:(20):1195-1201

HSL3063
Christensen DB, Bush PJ.
Drug prescribing: patterns, problems and proposals.
Soc Sci Med [A] 1981 May;15:(3):

HSL8536
Tidball P.
The pharmaceutical industry's responsibilities in the prescription process.
Can Pharm J 1981 May;114:(5):177-9

HSL8475
Generic Rxs rise by 5.9% as branded Rxs increase by only 1.6%
Pharmacy Times 1981 Apr;47:17-25

HSL8537
Martucci HJ, Parry MF.
Cephalosporin cost reduction.
Hosp Formul 1981 Apr;16:(4):396-8,

HSL3064
Curry L, Putnam RW.
Continuing medical education in Maritime Canada: the methods physicians use, would prefer and find most effective.
Can Med Assoc J 1981 Mar 1;124:(5):563-6

HSL8530
Pharmacy and manufacturer relations
Apothecary 1981 Mar;93:10-17

HSL8540
Strickland HODGE, Jepson MH.
Typing prescribers by reaction to medical detailing
Chemist and Druggist 1981 Feb 21;215:346, 352

HSL8535
Dickinson JG.
Reagan era and pharmacy
Drug Topics 1981 Feb 20;125:40-43

HSL3075
Hemminki E.
Quality of reports of clinical trials submitted by the drug industry to the Finnish and Swedish control authorities.
Eur J Clin Pharmacol 1981 Feb;19:(3):157-65

HSL3089
Pharmaceutical prices in Canada: guiding principles for government policy
Pharmaceutical Manufacturers Association of Canada 1981 Feb;

HSL3074
Gustafsson LL, Wide K.
Marketing of obsolete antibiotics in Central America.
Lancet 1981 Jan 3;1:(8210):31-3

HSL18712
Friedman JA, Alkhateeb W
Exporting Exploitation: The Dumping of U. Banned Pharmaceuticals in LDC's
Int Q Community Health Educ 1981 Jan 1;2:(4):289-99
http://www.ncbi.nlm.nih.gov/pubmed/20841092

HSL2087
Fazio RH, Zanna MP.
Direct experience and attitude-behavior consistency.
Berkowitz L. Advances in experimental social psychology New York: Academic Press 1981
http://www.amazon.co.uk/exec/obidos/ASIN/0120152134/qid=1124174696/sr=8-5/ref=sr_8_xs_ap_i5_xgl/026-3368758-1517268

HSL3060
Journal IN.
Lancet 1981;2:801

HSL3061
Berry EM.
The evolution of scientific and medical journals
New England Journal of Medicine 1981;305:400-402

HSL3062
Blum R, Kreitman K.
Factors affecting individual use of medicines
1981;122-185

HSL3065
Goldbloom D.
Drug companies and medical education: a modest proposal
McGill Medical Journal 1981;46:(2):24

HSL3076
Hibberd PL, Meadows AJ.
The pharmaceutical industry as a provider of drug information
Journal of Research Communication Studies 1981;3:289-297

HSL3077
Hymans R.
NZ Institute of Medical Representatives
New Zealand Medical Journal 1981;94:11

HSL3078
Jayasuriya DC.
Regulating the drug trade in the Third World
World Health Forum 1981;2:423-426

HSL3080
Leffler KB.
Persuasion or information? The economics of prescription drug advertising
Journal of Law and Economics 1981;24:45-74

HSL3081
Mark JA, Honigman B.
The weight of evidence
New England Journal of Medicine 1981;305:175

HSL3082
Meadows R.
Communicating new drug information—the medium is the message
Drug Information Journal 1981;15:11-15

HSL3084
Parsons LJ, Abeele PV.
Analysis of sales call effectiveness
Journal of Marketing Research 1981;18:107-113

HSL3085
Schneiweiss F.
Pharmaceutical advertising and the medical journal
Drug Information Journal 1981;15:193-197

HSL3086
Seaman B, Seaman G.
Women and the crisis in sex hormones
1981;

HSL3087
Silverman M, Lydecker M.
The promotion of prescription drugs and other puzzles
1981;78-92

HSL3088
Tennent RB.
Trade representatives
New Zealand Medical Journal 1981;93:314

HSL3090
Drug and Therapeutics Bulletin
British Journal of Hospital Medicine 1981;25:309

HSL3091
Turner P.
Drug and Therapeutics Bulletin
Drug and Therapeutics Bulletin 1981;25:309

HSL8533
Nordahl V.
Analgetics sales without prescription-should the selection and consumption be changed?
Norsk Farmaceutisk Tidsskrift 1981;89:(1-2):4-7

HSL9078
Melrose D.
The Great Health Robbery
: Oxfam 1981

HSL19395
Leffler K
Persuasion or information? the economics of prescription drug advertising.
J Law Econ 1981;24:45–74
http://www.jstor.org/pss/725202

HSL3059
Ross V.
Between bliss and bedlam
Maclean’s (Toronto) 1980 Dec 838-40, 42, 44

HSL3033
Hemminki E, Falkum E.
Psychotropic drug registration in the Scandinavian countries: the role of clinical trials.
Soc Sci Med [Med Psychol Med Sociol] 1980 Dec;14A:(6):547-59

HSL3046
Strickland-Hodge B, Jeqson MH.
Usage of information sources by general practitioners.
J R Soc Med 1980 Dec;73:(12):857-62

HSL8534
Bush PJ.
Prescribing is a social process
1980 Nov;1:VIII-X

HSL5373
Relman AS.
The new medical-industrial complex.
N Engl J Med 1980 Oct 23;303:(17):963-70

HSL8543
Makers campaign harder for votes of RPhs dispensing generically
American Druggist 1980 Oct;182: 44, 46, 48, 50, 52, 56, 58, 6

HSL8527
Fink JL.
FDA's dispensing container specifications and the pharmacist
Pharm Manage 1980 Sep-Oct;152:197-198

HSL3058
Peart WS.
The pharmaceutical industry: research and responsibility.
Lancet 1980 Aug 30;2:(8192):465-6

HSL3028
Epstein P, Yudkin JS.
Agranulocytosis in Mozambique due to amidopyrine, a drug withdrawn in the west.
Lancet 1980 Aug 2;2:(8188):254-5

HSL18279
de Andrade CD
O Homem e o Remédio: Qual o problema (People and medicines: What's wrong?)
Jornal do Brasil 1980 July 26

HSL3029
Gambrill J, Bridges-Webb C.
Use of sources of therapeutic and prescribing information by general practitioners.
Aust Fam Physician 1980 Jul;9:(7):482-4

HSL3057
Siskind V.
Prescription drug advertising
Medical Journal of Australia 1980 Jun 14;67:615, 617

Page 198 of 206 pages ‹ First  < 196 197 198 199 200 >  Last ›

 

  Healthy Skepticism on RSS   Healthy Skepticism on Facebook   Healthy Skepticism on Twitter

Please
Click to Register

(read more)

then
Click to Log in
for free access to more features of this website.

Forgot your username or password?

You are invited to
apply for membership
of Healthy Skepticism,
if you support our aims.

Pay a subscription

Support our work with a donation

Buy Healthy Skepticism T Shirts


If there is something you don't like, please tell us. If you like our work, please tell others.